SEC Form 4 · accession 0001209191-18-025693

GLOBUS MEDICAL INC · GMED

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Officer — Chief Executive Officer · Director

Period of report

Apr 18, 2018

Accepted (ET)

Apr 20, 2018 · 4:07 pm EDT

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0001237831

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I
Class A Common Stock	Apr 18, 2018	M	43,163	$23.95	A	192,018	D
Class A Common Stock^F2	Apr 18, 2018	S	43,163	$51.0001	D	148,855	D
Class A Common Stock	Apr 18, 2018	M	8,899	$24.10	A	157,754	D
Class A Common Stock^F2	Apr 18, 2018	S	8,899	$51.0001	D	148,855	D
Class A Common Stock	Apr 19, 2018	M	68,184	$24.10	A	217,039	D
Class A Common Stock	Apr 19, 2018	S	68,184	$51.00	D	148,855	D
Class A Common Stock	Apr 19, 2018	M	28,863	$25.52	A	177,718	D
Class A Common Stock	Apr 19, 2018	S	28,863	$51.00	D	148,855	D

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	Owned after	D/I
Stock Option (Right to Buy Class A Common Stock)^F3	$23.95	Apr 18, 2018	M	43,163	D	—	Jan 23, 2024	Class A Common Stock	43,163	0	D
Stock Option (Right to Buy Class A Common Stock)^F4	$24.10	Apr 18, 2018	M	8,899	D	—	Jan 20, 2025	Class A Common Stock	8,899	91,101	D
Stock Option (Right to Buy Class A Common Stock)^F4	$24.10	Apr 19, 2018	M	68,184	D	—	Jan 20, 2025	Class A Common Stock	68,184	22,917	D
Stock Option (Right to Buy Class A Common Stock)^F5	$25.52	Apr 19, 2018	M	28,863	D	—	Jan 25, 2026	Class A Common Stock	28,863	31,137	D

F1This sale was effected pursuant to a Rule 10b5-1 trading plan executed by the reporting person.
F2The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $51.00 to $51.03, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4.
F3These options were granted on January 23, 2014, and vest over a four-year period with one-fourth (1/4) of the options granted vesting on January 1, 2015, the first anniversary of the vesting commencement date, and the balance of the options granted vesting ratably on a monthly basis over the following 36 months.
F4These options were granted on January 20, 2015, and vest over a four-year period with one-fourth (1/4) of the options granted vesting on January 1, 2016, the first anniversary of the vesting commencement date, and the balance of the options granted vesting ratably on a monthly basis over the following 36 months
F5These options were granted on January 25, 2016, and vest over a four-year period with one-fourth (1/4) of the options granted vesting on January 1, 2017, the first anniversary of the vesting commencement date, and the balance of the options granted vesting ratably on a monthly basis over the following 36 months.